Ginkgo Advisory · Insights

Electroencephalographs: UK MHRA CFS, Registration and Apostille

Ginkgo Advisory

A UK MHRA Certificate of Free Sale (CFS) for electroencephalographs supports overseas documentation for registered EEG recording equipment. Its schedule identifies selected systems alongside the manufacturer’s channel configurations, acquisition software, accessory descriptions and conformity records for the exported presentation.

The issued certificate can then be prepared for overseas use through verification, professional certification, an apostille and any required embassy legalisation.

Product category and MHRA registration: Electroencephalographs

Electroencephalographs intended to record electrical activity of the brain for a medical purpose are general medical devices. Their documented configurations may include electrode inputs, amplifiers, recording units and analysis software. Stationary, portable and ambulatory designs have their own intended operating environments. Additional functions or stimulation components belong to the description only where included in the manufacturer’s stated intended purpose.

The MHRA’s Device Online Registration System, or DORS, holds manufacturer, device and product records. Registration includes the relevant conformity information, such as CE or UKCA documentation, together with the details identifying the products. For manufacturers based outside the UK, a UK Responsible Person represents the manufacturer for the Great Britain registration process.

The MHRA’s medical device registration guidance explains the registration framework. The April 2026 reference guide describes how these records are entered and maintained in the online system.

For Great Britain, the manufacturer’s records sit within the UK medical device framework. A CFS order is submitted by an eligible UK-based manufacturer or UK Responsible Person, using registered products and the relevant CE or UKCA conformity evidence.

Documents and product information

The registration process brings together information about the manufacturer, the product and its conformity documentation. The main records include:

  • Manufacturer details: the legal manufacturer’s name, registered address and contact information.
  • UK Responsible Person documentation: representative details and the designation agreement, where applicable.
  • Product details: system name, model, catalogue reference, legal manufacturer, channel configuration, amplifier and acquisition unit references, and relevant software versions. Labels, instructions, conformity documents and technical records describe signal acquisition, electrical safety, electromagnetic compatibility and applicable software performance. Electrode, lead and accessory lists identify supported connections, supplied components and documented cleaning or reuse arrangements where relevant.
  • Registration identifiers: the GMDN code and term, with Basic UDI-DI and UDI-DI where applicable.
  • Conformity documentation: the Declaration of Conformity and applicable conformity assessment certificates, including their references, validity and product schedules.
  • Supporting product records: labels, instructions for use and the technical and performance documentation held by the manufacturer.

The online registration links the relevant conformity documents to the device record and identifies the individual products beneath it. The wider technical documentation supports the manufacturer’s compliance records; it is not a separate standard upload package for each CFS order.

From MHRA registration to an electronic CFS

  1. Accepted registration establishes the manufacturer, device and individual product records in DORS. Current conformity documents are linked to the relevant entries.
  2. The applicant selects the products marked CFS Ready and reviews the certificate and schedule preview. Model names and catalogue references come from the registered product data.
  3. After the order is submitted and paid for, the MHRA issues an electronically signed PDF. The complete certificate and every schedule page form the document set for subsequent verification and legalisation.

The MHRA CFS Reference Guide describes these stages. The published CFS service information gives an issuance aim of ten working days, with longer processing possible during busy periods.

Product coverage in the CFS schedule

EEG systems can share a commercial family name while using different amplifiers, channel counts or software options. Configuration records identify the particular system represented by each registered entry. Electrode caps, individual electrodes, recording modules and other separately marketed components can have their own references. The CFS schedule follows the products selected for the order rather than the full equipment catalogue. Complete schedule pages and model descriptions help the overseas recipient connect the exported recording system and any listed accessories to the certificate’s actual product coverage.

Direct verification of the CFS with the MHRA

For an overseas submission, the authenticity of the issued certificate is an important part of document preparation. Ginkgo Advisory can arrange for a solicitor to seek direct confirmation of the CFS with the MHRA and review the certificate together with its schedule.

Solicitor certification and express UK FCDO apostille

Where the solicitor-certified route is accepted for the intended submission, Ginkgo Advisory can arrange solicitor certification followed by a UK FCDO paper apostille. The certification format is matched to the receiving authority’s requirements. MHRA’s published guidance describes a notarial route, and notarisation is arranged where that route is required.

Our express UK FCDO apostille service normally takes two working days once verification and the required certification are complete and the document is accepted for submission. The apostille stage has its own timetable, separate from MHRA certificate issuance, verification responses, any embassy processing and delivery. Further FCDO checks can affect completion.

Embassy legalisation for Egypt, the UAE, Kuwait and Qatar

Ginkgo Advisory can arrange embassy legalisation where required, bringing the verification, certification, apostille and relevant embassy submission into one coordinated service. The destination and intended use determine the required document format and any additional stages.

Preparing an issued MHRA CFS for overseas use

For a quotation, the starting documents are the MHRA-issued electronic PDF and all accompanying schedule pages. The issuance email, destination country, receiving authority’s instructions and required completion date help establish the appropriate preparation and delivery arrangements.

Contact Ginkgo Advisory with the issued CFS for a quotation covering direct MHRA verification, solicitor certification where accepted, express FCDO apostille and any required embassy legalisation.

Product questions

Are all electrode caps included on an EEG system’s CFS?

The system description identifies its supplied electrodes and supported connections. Compatibility with an EEG system does not itself identify an electrode cap as a listed product. The relevant registered entries, component descriptions and issued schedule establish which systems and separately marketed accessories are covered.

MHRA reference guides